Congenica Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 108
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $50.4M
Latest Deal Amount
  • Investors
  • 19

Congenica General Information

Description

Developer of a clinical genome interpretation technology designed to identify genetic diseases in patients. The company's medical technology processes genomic datasets to detect mutations by filtering clinically relevant variants and deep clinical phenotyping, enabling clinicians and researchers to interrogate the human genome to identify disease-causing variants.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Biotechnology
Primary Office
  • Wellcome Genome Campus
  • BIC Building
  • Cambridge CB10 1DR
  • England, United Kingdom
+44 01223 000000

Congenica Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Congenica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 09-Nov-2020 $50.4M 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series B) 30-Apr-2019 000.00 000.00 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 01-Jan-2016 00.000 Completed Generating Revenue
6. Grant 29-Sep-2015 00000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Apr-2015 00.000 00.000 00.00 Completed Generating Revenue
4. Grant 11-Mar-2015 00.000 00.000 Completed Startup
3. Seed Round 05-Dec-2014 00.000 00.000 Completed Startup
2. Seed Round 01-Oct-2014 $814K $814K 00.000 Completed Startup
1. Grant 02-May-2014 $570K Completed Startup
To view Congenica’s complete valuation and funding history, request access »

Congenica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
B Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
B Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 4,396,070 $0.001301 $0.65 $0.65 1x $0.65 7.82%
A Ordinary 2,553,500 $0.001301 $0.25 $0.25 1x $0.25 4.54%
To view Congenica’s complete cap table history, request access »

Congenica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a clinical genome interpretation technology designed to identify genetic diseases in patients. The company'
Decision/Risk Analysis
Cambridge, United Kingdom
108 As of 2022
000.00
0000 0000-00-00
00000000000 000.00

0000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000000000000 00000000
Boston, MA
000 As of 0000
00000
0000 0000-00-00
000000&0 00000

000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
00000 0000000000 0000000000 0000000
Palo Alto, CA
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Congenica Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genuity Science Formerly VC-backed Boston, MA 000 00000 000000&0 00000
000000 Venture Capital-Backed Palo Alto, CA 00 0000 00000000000 0000
00000 Venture Capital-Backed San Mateo, CA 000 00000 00000000000 00000
000000 00000000 Formerly VC-backed San Francisco, CA 0 00.00 000000&0 00.00
0000000000 (000000 Venture Capital-Backed New York, NY 00 000.00 00000000000 000.00
You’re viewing 5 of 30 competitors. Get the full list »

Congenica Patents

Congenica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2591115-A Screening system and method for acquiring and processing genomic information for generating gene variant interpretations Pending 16-Jan-2020 000000000
GB-2587238-A Kit and method of using kit Pending 20-Sep-2019 0000000000
GB-201916002-D0 System and method for copy number variant error correction Pending 22-Jul-2019 000000000
GB-201910478-D0 System and method for copy number variant error correction Ceased 22-Jul-2019 000000000
GB-2585958-A System and method for copy number variant error correction Pending 22-Jul-2019 G16B20/10
To view Congenica’s complete patent history, request access »

Congenica Executive Team (20)

Name Title Board Seat Contact Info
David Atkins Ph.D Chief Executive Officer & Board Member
Jayesh Pankhania Chief Financial Officer
Nicholas Lench Ph.D Co-Founder, Chief Operating Officer, Chief Scientific Officer & Board Member
Rob Denison Chief Information Officer
Richard Durbin Co-Founder & Informatics Director
You’re viewing 5 of 20 executive team members. Get the full list »

Congenica Board Members (17)

Name Representing Role Since
Alastair Kilgour Parkwalk Advisors Board Member 000 0000
Andrew Richards Ph.D Congenica Chairman 000 0000
David Atkins Ph.D Congenica Chief Executive Officer & Board Member 000 0000
Heiner Dreismann Ph.D Self Board Member 000 0000
Matthew Hurles Ph.D Congenica Co-Founder, Scientific Director & Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Congenica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Congenica Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Downing Asset Manager Minority 000 0000 000000 0
IDO Investments Venture Capital Minority 000 0000 000000 0
Legal & General Group Other Minority 000 0000 000000 0
Puhua Capital Venture Capital Minority 000 0000 000000 0
Renaissance Capital Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »